How European Cannabis Seed Companies Are Quietly Taking Over The U.S. Market
The U.S. cannabis seed market will be valued reaching $2.02 billion by 2030
The cannabis industry owes much of its foundation to one simple but often overlooked component: the seed. While modern, commercial cultivation frequently relies on cloning and tissue culture to maintain genetic consistency, seeds remain essential for biodiversity and the expansion of cannabis genetics. Despite being the cornerstone of cannabis cultivation, seeds have long taken a backseat in the broader U.S. market, overshadowed by products with mass appeal like flower, edibles and concentrates. Yet a significant shift is underway. European cannabis seed companies are capitalizing on the rising trend of home cultivation, redefining their role as a key driver of the industry’s growth.
In 2022, the U.S. cannabis seed market was valued at $567.76 million and is projected to grow at a compound annual growth rate (CAGR) of 17.2%, reaching $2.02 billion by 2030, according to Data Bridge Market Research. This rapid growth, fueled by legalization efforts and the rise of home cultivation, represents a golden opportunity for European leaders like Blimburn Seeds, Royal Queen Seeds, ILGM and Zamnesia.
Blimburn, for instance, reports annual sales of 12 to 15 million seeds globally, with approximately 8 million sold in the U.S. alone. The company generates close to €8 million ($8.24 million) annually, evidencing the growing demand for quality cannabis seeds, particularly among home growers. Similarly, ILGM (I Love Growing Marijuana), founded in 2012, highlights its significant reach, having reportedly sold more than 30 million seeds to one million home growers across the U.S. since its inception.
To Read The Rest Of This Article On Forbes, Click Here
